Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

タモキシフェンと予防

A Z Bluming

    Lancet (London, England)
    |March 13, 1993
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Authorization of anastrazole to prevent breast cancer in postmenopausal women: a bad idea.

    Climacteric : the journal of the International Menopause Society·2024
    Same author

    Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know?

    Climacteric : the journal of the International Menopause Society·2012
    Same author

    What are the real risks for breast cancer?

    Climacteric : the journal of the International Menopause Society·2011
    Same author

    Syngeneic marrow transplantation in patients with multiple myeloma.

    Bone marrow transplantation·1996
    Same author

    Breast cancer and hormone-replacement therapy.

    The New England journal of medicine·1995
    Same author

    Hormone replacement therapy: benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer.

    Seminars in oncology·1993
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る